It was a controversial choice for Annovis Bio to change the endpoint of a Phase ...
Annovis Bio delivers candor on its Parkinson’s study, even if it doesn’t inspire...
People are choosing home birth for vaginal delivery after cesarian and other hig...
STAT+ subscribers tried to stump Pharmalot, aka Ed Silverman. Here’s what they c...
Abridge, a Pittsburgh AI startup emerging as a challenger to Microsoft’s clinica...
The FDA said it is not planning to take a tougher stance against wayward clinica...
This week on "The Readout LOUD" podcast: What do CEOs owe the world? Did Humira ...
Embryo loss is integral to IVF. Alabama’s ruling equating embryos with children ...
San Diego-based Neurocrine Biosciences joins PhRMA as trade group rebuilds its m...
A bizarre court case led to an unthinkable ruling in Alabama that effectively li...
Community Health Systems is facing a new federal probe into its hospital billing...
Colorado could be the first state to bring action against a drug maker via a sta...
A Florida state policy set amid a measles outbreak in Broward County has vaccina...
The good news for Novavax is that it’s no longer facing a $700 million dispute w...
In a victory for the pharmaceutical industry, Oregon officials have suspended a ...
Colorado moves to cap the price of Etanercept, an autoimmune drug sold by Amgen ...
